FI895976A0 - Polyhydroxibenzyloxipropanolaminer. - Google Patents

Polyhydroxibenzyloxipropanolaminer.

Info

Publication number
FI895976A0
FI895976A0 FI895976A FI895976A FI895976A0 FI 895976 A0 FI895976 A0 FI 895976A0 FI 895976 A FI895976 A FI 895976A FI 895976 A FI895976 A FI 895976A FI 895976 A0 FI895976 A0 FI 895976A0
Authority
FI
Finland
Prior art keywords
polyhydroxibenzyloxipropanolaminer
Prior art date
Application number
FI895976A
Other languages
English (en)
Finnish (fi)
Inventor
Ghanshyam Patil
William L Matier
Khuong H X Mai
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of FI895976A0 publication Critical patent/FI895976A0/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/62—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI895976A 1988-12-15 1989-12-14 Polyhydroxibenzyloxipropanolaminer. FI895976A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/285,005 US4959390A (en) 1988-12-15 1988-12-15 Polyhydroxybenzyloxypropanolamines

Publications (1)

Publication Number Publication Date
FI895976A0 true FI895976A0 (fi) 1989-12-14

Family

ID=23092337

Family Applications (1)

Application Number Title Priority Date Filing Date
FI895976A FI895976A0 (fi) 1988-12-15 1989-12-14 Polyhydroxibenzyloxipropanolaminer.

Country Status (14)

Country Link
US (1) US4959390A (no)
EP (1) EP0373591A3 (no)
JP (1) JPH02258749A (no)
AU (1) AU621698B2 (no)
CA (1) CA2005374A1 (no)
DK (1) DK634089A (no)
FI (1) FI895976A0 (no)
HU (1) HU204768B (no)
IL (1) IL92650A0 (no)
NO (1) NO895040L (no)
NZ (1) NZ231754A (no)
PT (1) PT92588A (no)
RU (1) RU1836330C (no)
ZA (1) ZA899620B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5064827A (en) * 1988-12-15 1991-11-12 Du Pont Merck Pharmaceutical Company Polyhydroxybenzyloxpropanolamines
US4935422A (en) * 1988-12-15 1990-06-19 E. I. Du Pont De Nemours And Company Acyloxypropanolamines
GB9312893D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
US6031109A (en) * 1993-06-22 2000-02-29 Knoll Aktiengesellschaft Phenoxy-, phenylthio-, benzoyl-alkyleneaminoalkylene-imidazole derivatives as therapeutic agents
US5536749A (en) * 1994-10-13 1996-07-16 Sl Pharmaceuticals, Inc. Method for attenuation of sympathetic nervous system activity or onset of migraine by selectively metabolized beta-blocking agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE56533C (de) * W. W. MUTTER in Islay, Grafsch. Argyle, Schottland, und W. DAWSON in Bishop Street, Glasgow, Grafsch. Lanark, Schottland Probenehmer für Flüssigkeiten
SE384853B (sv) * 1972-04-04 1976-05-24 Haessle Ab Forfarande for framstellning av nya aminer
FR2479814A1 (fr) * 1980-04-04 1981-10-09 Fabre Sa Pierre Phenyl alcoxy propanolamines, leur preparation et leur application en tant que medicaments
FI76551C (fi) * 1980-11-06 1988-11-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 3-aminopropoxifenylderivat.
AU601948B2 (en) * 1985-05-14 1990-09-27 William John Louis 3-aminopropyloxyphenyl derivatives their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EP0373591A2 (en) 1990-06-20
US4959390A (en) 1990-09-25
AU621698B2 (en) 1992-03-19
NZ231754A (en) 1992-03-26
HU896636D0 (en) 1990-02-28
AU4679689A (en) 1990-06-21
NO895040L (no) 1990-06-18
JPH02258749A (ja) 1990-10-19
PT92588A (pt) 1990-06-29
EP0373591A3 (en) 1991-03-20
ZA899620B (en) 1991-08-28
HUT53591A (en) 1990-11-28
DK634089A (da) 1990-06-16
DK634089D0 (da) 1989-12-14
NO895040D0 (no) 1989-12-14
IL92650A0 (en) 1990-08-31
RU1836330C (ru) 1993-08-23
CA2005374A1 (en) 1990-06-15
HU204768B (en) 1992-02-28

Similar Documents

Publication Publication Date Title
DE68906637T2 (de) Waferträger.
DE58905119D1 (de) Heteroaryloxyessigsaeure-n-isopropylanilide.
FI894021A0 (fi) Neuronstruktur.
DE3876988T2 (de) Loetgeraet.
DE68921898T2 (de) Ringbinder.
DE58904437D1 (de) Rakelfarbwerk.
DE58904326D1 (de) Rakelfarbwerk.
DE58902774D1 (de) Pflanztafel.
DE68909215D1 (de) Laseroszillator.
DE58902346D1 (de) Traenkeventil.
DE58903112D1 (de) Kannenstock.
NO891271D0 (no) Folde-eske.
DE68901775D1 (de) Mammographiegeraet.
FI895976A0 (fi) Polyhydroxibenzyloxipropanolaminer.
FI911457A0 (fi) Skydd foer en gasisolerad medelspaenningsbelastningskoppling.
DE58900554D1 (de) Aminoguanidinoazine.
DE58903712D1 (de) Gegenseheinrichtung.
FI894479A0 (fi) Stabiliseringssystem foer laettviktsvapen.
DE325410T1 (de) Passphotokamera.
DE68905146T2 (de) Indanderivate.
DE68904912T2 (de) Ringlaser-kreisel.
DE58908380D1 (de) Benzofuranylbiphenyle.
ES1007733Y (es) Arqueta.
DE68905196T2 (de) Faschine.
FI80861B (fi) Plastdosa.

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: THE DU PONT MERCK PHARMACEUTICAL COMPANY